Denmark's Novo Nordisk to buy Dicerna Pharma for $3.3 billion
Nov 18 (Reuters) - Danish drugmaker Novo Nordisk has agreed a $3.3 billion cash deal to buy Dicerna Pharmaceuticals which specializes in therapeutics that ...
Nov 18 (Reuters) - Danish drugmaker Novo Nordisk has agreed a $3.3 billion cash deal to buy Dicerna Pharmaceuticals which specializes in therapeutics that ...